If you would like to request hard copies of any of these publications please send an email to lmichel@ipmglobal.org. Please indicate the publication, the language(s), and the approximate timeframe in which you would like to receive the materials.
IPM researchers have authored a chapter in a comprehensive new HIV prevention, care and treatment guide published by the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF).
The guide, From the Ground Up: Building Comprehensive HIV/AIDS Care Programs in Resource-Limited Settings, features the work of 230 public health experts from around the world. It builds on lessons learned from the last 20 years in HIV prevention, care and treatment. The foundation unveiled the guide Aug. 5 at the International AIDS Conference in Mexico City. For additional information click here.
The publications listed below are available in Adobe PDF format. (Click here if you need to download a free version of Adobe Reader.)
The publications listed below are available in Adobe PDF format. (Click here if you need to download a free version of Adobe Reader.)
The publications listed below are available in Adobe PDF format. (Click here if you need to download a free version of Adobe Reader.)
The publications listed below are available in Adobe PDF format. (Click here if you need to download a free version of Adobe Reader.)
The publications listed below are available in Adobe PDF format. (Click here if you need to download a free version of Adobe Reader.)
The publications listed below are available in Adobe PDF format. (Click here if you need to download a free version of Adobe Reader.)
Abstracts for journal articles based on IPM-supported research are available on the U.S. National Library of Medicine’s PubMed Website along with links to sites where the articles can be purchased.
 |
| Title and Journal |
Author(s) |
Publication Date |
|
Ensuring that Developing Countries have Access to New Healthcare Products: The Role of Product Development Partnerships. Download PDF
Innovation Strategy Today |
Brooks AD, Wells WA, McLean TD, Khanna R, Coghlan R, Mertenskoetter T, Privor-Dumm LA, Krattiger A, Mahoney RT |
January 2010 |
Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women.
Journal of Acquired Immune Deficiency Syndromes |
Nel A, Smythe S, Young K, Malcolm K, McCoy C, Rosenberg Z, Romano J |
August 2009 |
Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy HIV-negative women.
AIDS |
Nel A, Coplan P, van de Wijgert J, Kapiga S, von Mollendorf C, Geubbels E, Vyankandondera J, Rees H, Masenga G, Kiwelu I, Moyes J, Smythe S |
July 2009 |
Safety Evaluation of 1% Tenofovir Gel in Healthy Men.
International Journal of STD and AIDS |
Schwartz J, Poindexter A, Wheeless A, Mauck C, Callahan M |
June 2009 |
Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring.
AIDS Research and Human Retroviruses |
Romano J, Variano B, Coplan P, Van Roey J, Douville K, Rosenberg Z, Temmerman M, Verstraelen H, Van Bortel L, Weyers S, Mitchnick M |
May 2009 |
The Future of HIV Microbicides: Challenges and Opportunities.
Antiviral Chemistry and Chemotherapy |
Garg A, Nuttall J, Romano J |
April 2009 |
Characterization of Vaginal Transmission of a Simian Human Immunodeficiency Virus (SHIV) Encoding the Reverse Transcriptase Gene from HIV-1 in Chinese Rhesus Macaques.
Virology |
Pal R, Nuttall J, Galmin L, Weiss D, Chung H-K, Romano J |
March 2009 |
Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor.
Antimicrobial Agents and Chemotherapy |
Fletcher P, Harman S, Azijn H, Armanasco N, Manlow P, Perumal D, de Bethune M-P, Nuttall J, Romano J, Shattock R |
February 2009 |
Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1.
Journal of Pharmaceutical Sciences |
Gupta K, Pearce S, Poursaid A, Aliyar H, Tresco P, Mitchnick M, et al. |
October 2008 |
Microbicide delivery: formulation technologies and strategies.
Current Opinion in HIV and AIDS |
Romano J, Malcolm R, Garg S, Rohan L, Kaptur PE |
August 2008 |
The paradoxical effect of using antiretroviral-based microbicides to control HIV epidemics.
Proceedings of the National Academy of Sciences |
Wilson D, Coplan P, Wainberg M, Blower S |
July 2008 |
Concentrations of Dapivirine in the Rhesus Macaque and Rabbit Following Once Daily Intravaginal Administration of a Gel Formulation of [14C]Dapivirine for 7 Days.
Antimicrobial Agents and Chemotherapy |
Nuttall J, Thake D, Lewis M, Ferkany J, Romano J, and Mitchnick M |
March 2008 |
Challenges of producing a drug primarily for use in developing countries: miocrobicides for HIV prevention.
Future Medicine – HIV Therapy (abstract) |
Nuttall J, Douville K, Galbreath C, Walker S, Norick P, Rosenberg Z. |
November 2007 |
The Future of HIV Prevention: Prospects for an Effective Anti-HIV Microbicide.
Infectious Disease Clinics of North America |
Nuttall J, Romano J, Douville K, Galbreath C, Nel A, Heyward W, Mitchnick M, Walker S and Rosenberg Z |
March 2007 |
Temperature and pH sensitive hydrogels: an approach towards smart semen-triggered vaginal microbicidal vehicles.
Journal of Pharmaceutical Sciences |
Gupta K, Barnes S, Tangaro R, Roberts M, Owen D, Katz D, et al. |
March 2007 |
Characterization of silicone elastomer vaginal rings containing HIV microbicide TMC120 by Raman spectroscopy.
Journal of Pharmacy and Pharmacology |
Bell S, Dennis A, Fido L, Malcolm R, Sirimuthu M, Toner C and Woolfson A |
February 2007 |
Microbicides for HIV/AIDS. 2. Electrophoretic Fingerprinting of CD4+ T-Cell Model Systems.
Langmuir: The American Chemical Society Journal of Surfaces and Colloids |
Fairhurst D, Rowell R, Monahan I, Key S, Stieh D, McNeil-Watson F, Morfesis A, Mitchnick M and Shattock R |
February 2007 |
Intravaginal ring delivery of the reverse transcriptase inhibitor TMC120 as an HIV microbicide.
International Journal of Pharmaceutics |
Woolfson A, Malcolm R, Morrow R, Toner C and McCullagh S |
November 2006 |
Microbicides for the prevention of HIV infection in women: an overview of recent trials.
Current Opinion on HIV and AIDS |
Rosenberg Z, Nel A, Heyward W, Mitchnick M |
November 2006 |
Preparing for microbicide trials in Rwanda: Focus group discussions with Rwandan women and men.
Culture, Health & Sexuality |
Veldhuijzen N, Nyinawabega J, Umulisa M, Kankindi B, Geubbels E, Basinga P, Vyankandondera J and Van De Wijgert J |
September-October 2006 |
Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?
Antiviral Research |
Martinez J, Coplan P and Wainberg M |
September 2006 |
Challenges to microbicide introduction in South Africa.
Social Science & Medicine |
Orner P, Harries J, Cooper D, Moodley J, Hoffman M, Becker J, McGrory E, Dabash R and Bracken H |
August 2006 |
Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings.
Journal of Antimicrobial Chemotherapy |
Malcolm R, Woolfson A, Toner C, Morrow R and McCullagh S |
November 2005 |
Microbicides for HIV/AIDS. 1. Electrophoretic Fingerprinting the H9 Cell Model System.
Langmuir: The American Chemical Society Journal of Surfaces and Colloids |
Rowell R, Fairhurst D, Key S, Morfesis A, Monahan I, Mitchnick M and Shattock R |
October 2005 |
Manufacturing Microbicides.
Impact 10: HIV Prevention – Condoms and Beyond (PDF) |
Rosenberg Z |
June 2005 |
Strengthening Regulatory Capacity for Microbicides in Southern Africa.
The Microbicide Quarterly (PDF) |
Farley T, Malonza I and Coplan P |
April-June 2005 |
Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development.
Protein Expression and Purification |
Colleluori D, Tien D, Kang F, Pagliei T, Kuss R, McCormick T, et al. |
February 2005 |
Regulatory Challenges in Microbicide Development.
Science |
Coplan P, Mitchnick M and Rosenberg Z |
June 2004 |
|
 |
